Publications by authors named "Susanna Lunardini"
Article Synopsis
- Locally advanced or metastatic renal cell carcinomas (mRCCs) make up about 15% of kidney cancer cases, with systemic therapies, especially using tyrosine kinase inhibitors and immunotherapy, being the main treatment approach.
- A systematic review of literature, utilizing the PICO methodology, was conducted, which included seven studies on various types of miRNAs (plasmatic, exosomal, and urinary) involving 789 patients.
- Several specific miRNAs were linked to treatment resistance in mRCC, showing potential as biomarkers for predicting treatment outcomes; however, these findings are not yet validated for clinical use, indicating a need for further research.
